• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2001年法国前列腺癌的治疗及与根治性前列腺切除术相关的因素]

[Prostate cancer management and factors associated with radical prostatectomy in France in 2001].

作者信息

Jegu J, Tretarre B, Velten M, Guizard A-V, Danzon A, Buemi A, Colonna M, Kadi-Hanifi A-M, Ganry O, Molinie F, Bara S, Rebillard X, Grosclaude P

机构信息

Registre des cancers du Tarn, Albi, France.

出版信息

Prog Urol. 2010 Jan;20(1):56-64. doi: 10.1016/j.purol.2009.09.004. Epub 2009 Oct 14.

DOI:10.1016/j.purol.2009.09.004
PMID:20123529
Abstract

INTRODUCTION

Prostate cancer was the most common cancer in men in France in 2005, and the second cause of male death from cancer. In this study, we analyzed clinical characteristics of patients with prostate cancer diagnosed in France in 2001 with a focus on therapeutic management of localized prostate cancers.

PATIENTS AND METHODS

A total of 2181 cases of prostate cancer diagnosed in 2001 from 11 French counties covered by a cancer registry were analyzed. A descriptive study of the clinical characteristics of patients was performed. Parameters studied included age, county, TNM stage, PSA value, Gleason score, D'Amico prognostic group, Charlson's comorbidity index and initial treatment modalities. For localized cancers, multivariate logistic regression analysis identified factors associated with radical prostatectomy.

RESULTS

The proportion of localized prostate cancer (T1 or T2) was 86.6 %. The use of invasive curative treatment (radical prostatectomy and radiotherapy) was 58.4 % for localized cancers. Significant differences in therapeutic management were found between counties. Radical prostatectomy was associated with age at diagnosis, D'Amico prognostic group and the presence of comorbidities.

CONCLUSIONS

Most of prostate cancers diagnosed in France in 2001 were clinically localized and were treated by invasive therapy. The consequences of these practices remain to be determined given the limited evolution of many prostate cancers and the frequency of adverse events related to invasive treatments.

摘要

引言

前列腺癌是2005年法国男性中最常见的癌症,也是男性癌症死亡的第二大原因。在本研究中,我们分析了2001年在法国确诊的前列腺癌患者的临床特征,重点关注局限性前列腺癌的治疗管理。

患者与方法

对来自癌症登记处覆盖的法国11个县的2001年确诊的2181例前列腺癌病例进行了分析。对患者的临床特征进行了描述性研究。研究的参数包括年龄、县、TNM分期、PSA值、Gleason评分、达米科预后组、查尔森合并症指数和初始治疗方式。对于局限性癌症,多因素逻辑回归分析确定了与根治性前列腺切除术相关的因素。

结果

局限性前列腺癌(T1或T2)的比例为86.6%。局限性癌症采用侵入性根治性治疗(根治性前列腺切除术和放疗)的比例为58.4%。各县之间在治疗管理方面存在显著差异。根治性前列腺切除术与诊断时的年龄、达米科预后组和合并症的存在有关。

结论

2001年在法国确诊的大多数前列腺癌在临床上是局限性的,并采用侵入性治疗。鉴于许多前列腺癌进展有限以及与侵入性治疗相关的不良事件发生率,这些治疗方法的后果仍有待确定。

相似文献

1
[Prostate cancer management and factors associated with radical prostatectomy in France in 2001].[2001年法国前列腺癌的治疗及与根治性前列腺切除术相关的因素]
Prog Urol. 2010 Jan;20(1):56-64. doi: 10.1016/j.purol.2009.09.004. Epub 2009 Oct 14.
2
Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.结合活检侧别与TNM分期的改良临床分期系统用于T1c和T2期前列腺癌男性患者:SEARCH数据库的结果
J Urol. 2003 Jun;169(6):2129-35. doi: 10.1097/01.ju.0000065763.21602.14.
3
The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.前列腺癌干预与观察试验:退伍军人事务部/美国国立癌症研究所/医疗保健研究与质量局合作研究项目#407(PIVOT):一项随机对照试验的设计及基线结果,该试验比较了根治性前列腺切除术与对临床局限性前列腺癌男性进行观察等待的效果。
Contemp Clin Trials. 2009 Jan;30(1):81-7. doi: 10.1016/j.cct.2008.08.002. Epub 2008 Aug 23.
4
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.临床局限性前列腺癌根治性前列腺切除术后进展的长期风险:5年后仍有生化复发的持续风险。
J Urol. 2000 Jul;164(1):101-5.
5
[Cancer of the prostate in France: results of the survey CCAFU-FRANCIM].[法国前列腺癌:CCAFU-FRANCIM调查结果]
Prog Urol. 2001 Jun;11(3):478-85.
6
Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.根据临床Gleason评分和患者年龄,对临床非转移性前列腺腺癌根治性前列腺切除术后的竞争风险分析。
J Urol. 2002 Aug;168(2):525-9.
7
External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.临床分期为T1-2期前列腺癌的体外放射治疗与根治性前列腺切除术:根据治疗前前列腺特异性抗原(PSA)水平和活检Gleason评分分层的治疗意义
Cancer J Sci Am. 1997 Mar-Apr;3(2):78-87.
8
Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.根治性前列腺切除术治疗偶发性(T1a-T1b期)前列腺癌:残余疾病和生化复发的预测因素分析。
Eur Urol. 2008 Jul;54(1):118-25. doi: 10.1016/j.eururo.2008.02.018. Epub 2008 Feb 26.
9
Predicting pathological stage of localized prostate cancer using volume weighted mean nuclear volume.利用体积加权平均核体积预测局限性前列腺癌的病理分期。
J Urol. 2000 Nov;164(5):1587-90.
10
Prostate biopsy: who, how and when. An update.前列腺活检:对象、方法及时机。最新进展。
Can J Urol. 2005 Feb;12 Suppl 1:44-8; discussion 99-100.

引用本文的文献

1
Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.卡巴他赛治疗转移性去势抵抗性前列腺癌的总生存和无进展生存:FUJI 队列。
Br J Cancer. 2019 Dec;121(12):1001-1008. doi: 10.1038/s41416-019-0611-6. Epub 2019 Nov 13.
2
Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean.马提尼克岛前列腺癌患者的治疗模式:加勒比地区一项基于人群的研究结果。
BMC Cancer. 2018 Nov 16;18(1):1130. doi: 10.1186/s12885-018-5047-5.
3
Assessment of cancers' diagnostic stage in a Deaf community - survey about 4363 Deaf patients recorded in French units.
聋人社区癌症诊断阶段评估 - 对法国单位记录的 4363 名聋人患者的调查。
BMC Cancer. 2018 Jan 23;18(1):93. doi: 10.1186/s12885-017-3972-3.
4
Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study.年龄仍是局部前列腺癌未接受治愈性治疗的主要预测因素:一项基于人群的研究。
Br J Cancer. 2013 Jul 9;109(1):272-9. doi: 10.1038/bjc.2013.268. Epub 2013 May 30.